INNOVATIVE EYEWEAR, INC. Proceeds from Issuance or Sale of Equity
INNOVATIVE EYEWEAR, INC. (LUCY) reported Proceeds from Issuance or Sale of Equity of $3.00 million for the 1-month period ending 2026-07-31, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2026-08-14
- INNOVATIVE EYEWEAR, INC. proceeds from issuance or sale of equity for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- INNOVATIVE EYEWEAR, INC. proceeds from issuance or sale of equity for the quarter ending 2026-03-31 was $1.50M.
- INNOVATIVE EYEWEAR, INC. proceeds from issuance or sale of equity for the quarter ending 2025-12-31 was -$500.00K.
- INNOVATIVE EYEWEAR, INC. proceeds from issuance or sale of equity for the quarter ending 2025-06-30 was $2.60M.
- INNOVATIVE EYEWEAR, INC. proceeds from issuance or sale of equity for fiscal 2025 was $6.80M, a 35.24% decline from fiscal 2024.
- INNOVATIVE EYEWEAR, INC. proceeds from issuance or sale of equity for fiscal 2024 was $10.50M.
| Period end | Proceeds from Issuance or Sale of Equity 1 month | Proceeds from Issuance or Sale of Equity 3 month | Proceeds from Issuance or Sale of Equity 6 month | Proceeds from Issuance or Sale of Equity 9 month | Proceeds from Issuance or Sale of Equity 12 month |
|---|---|---|---|---|---|
| 2026-07-31 | $3.00M 10-Q · filed 2026-08-14 | ||||
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.50M 10-Q · filed 2026-08-14 | $1.00M derived: sum of 3 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $1.50M 10-Q · filed 2026-05-14 | $1.00M derived: sum of 2 quarters · filed 2026-05-14 | |||
| 2025-12-31 | -$500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $6.80M 10-K · filed 2026-03-25 | |||
| 2025-09-30 | $7.30M 10-Q · filed 2025-11-13 | ||||
| 2025-06-30 | $2.60M 10-Q · filed 2025-08-14 | ||||
| 2024-12-31 | $10.50M 10-K · filed 2026-03-25 | ||||
| 2024-03-31 | $1.25M 10-Q · filed 2025-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RxSight, Inc. (RXST) | United States | $0.197B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |